Letrozole Amarox (Letrozole)

Letrozole blocks the aromatase enzyme, which converts androgens into estrogen. By inhibiting this conversion, systemic estrogen levels fall, depriving hormone‑sensitive breast cancer cells of the growth signal they require.

The dosage of Letrozole Amarox is determined by the prescribing clinician based on the patient’s clinical condition, renal and hepatic function, and treatment setting. The prescriber will specify the exact regimen on the prescription.

Letrozole is contraindicated during pregnancy because it can cause fetal harm. Women of child‑bearing potential should use effective contraception. Safety in breastfeeding has not been established, and breastfeeding is generally discouraged while on therapy.

To order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Letrozole, anastrozole, and exemestane are all aromatase inhibitors. Letrozole is often considered the most potent in reducing estrogen levels, which may translate into slightly higher response rates in some studies, though individual patient tolerance and physician preference guide selection.

Letrozole Amarox tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep out of reach of children and do not use after the expiry date.

Letrozole Amarox is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional. Swallow the tablet whole with water; do not crush or chew unless specifically instructed.

Serious risks include severe liver injury, bone fractures due to decreased bone mineral density, pulmonary embolism, and rare allergic reactions such as anaphylaxis. Patients should report any signs of jaundice, sudden shortness of breath, severe bone pain, or rash to their physician promptly.

Letrozole is not recommended for premenopausal women, pregnant or nursing individuals, patients with known hypersensitivity to letrozole or its excipients, and those with severe hepatic impairment. Clinicians should also exercise caution in patients with a history of cardiovascular events.